← 홈

전체 프로그램

ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-12 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 4,162개
ADCBiologicstaleLaura Huppert, MD, BAPhase 2

Amiloride (Amiloride)

HER2 Low Breast Carcinoma; Triple Negative Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 30상태 RECRUITING
CGTBiologicChinese PLA General HospitalPhase 2

Anti-BCMA-CD19 CAR-T cells (Anti-BCMA-CD19 CAR-T cells)

IgG4 Related Disease; B-cell Mediated Autoimmune Disorders · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+5
임상시험 30상태 RECRUITING
CGTBiologicInstituto de Investigación Hosp…Phase 1

Autologous CD19/CD22 CAR T cells (Autologous CD19/CD22 CAR T cells)

Precursor Cell Lymphoblastic Leukemia-Lymphoma · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 30상태 RECRUITING
CGTBiologicstaleVaxcell Bio, Co., Ltd.Phase 1

Autologous Natural Killer Cell Therapy (Autologous Natural Killer Cell Therapy)

Hepatocellular Carcinoma · Hepatocellular Carcinoma

#HepatocellularCarcinoma#CGT#Phase1#세포유전치료#CAR-T+2
임상시험 30상태 RECRUITING
AntibodyNantes University HospitalPreclinical

Azathioprine + infliximab (Azathioprine + infliximab)

Crohn Disease · Crohn Disease

#CrohnDisease#Antibody#Preclinical#항체#면역항체+3
효능 ORR 6%임상시험 30상태 RECRUITING
CGTBiologicstaleBeijing BiotechPhase 1

B7-H3-CAR T Cells (B7-H3-CAR T Cells)

Central Nervous System Neoplasms; Atypical Teratoid/Rhabdoid Tumor · B7-H3

#B7-H3#CGT#Phase1#세포유전치료#CAR-T+5
임상시험 30상태 RECRUITING
ADCBiologicstaleSerum Life Science Europe GmbHPhase 2

Bacillus Calmette Guerin Vaccine (Bacillus Calmette Guerin Vaccine)

Non-muscle Invasive Bladder Cancer; HER-2 Protein Overexpression · Non-muscle Invasive Bladder Cancer

#Non-muscleInvasiveBladderCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 30상태 RECRUITING
AntibodystaleRochePhase 2

Bendamustine + Rituximab (Bendamustine + Rituximab)

Marginal Zone Lymphoma(MZL) · Chronic Lymphocytic Leukemia

#ChronicLymphocyticLeukemia#Antibody#Phase2#항체#면역항체+3
효능 ORR 95%임상시험 30상태 RECRUITING
CGTBiologicstaleMinsk Scientific-Practical Cent…Phase 2

CD19+22 CAR-T cells (CD19+22 CAR-T cells)

Acute Lymphobkastic Leukemia; B Cell Lymphoma · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+4
효능 ORR 1%임상시험 30상태 RECRUITING
AntibodystaleUCB PharmaPhase 3

CDP870 (Certolizumab Pegol, Certolizumab Pegol (CDP870))

Crohn's Disease · Crohn's Disease

#CrohnsDisease#Antibody#Phase3#항체#면역항체+2
효능 ORR 5%임상시험 30상태 ACTIVE
CGTBiologicstaleCenter for International Blood …Phase 2

Chronic Myeloid Leukemia + NK cell (Chronic Myeloid Leukemia + NK cell)

Chronic Myeloid Leukemia · Chronic Myeloid Leukemia

#ChronicMyeloidLeukemia#CGT#Phase2#세포유전치료#CAR-T+2
임상시험 30상태 ACTIVE
AntibodyRochePhase 2

Cohort C: bevacizumab (Cohort C: bevacizumab)

Acute Respiratory Distress Syndrome (ARDS); ARDS · Acute Respiratory Distress Syndrome (ARD

#AcuteRespiratoryDistressSyndrome#Antibody#Phase2#항체#면역항체+3
효능 ORR 60.9%임상시험 30상태 RECRUITING
ADCBiologicstaleEisai Inc.Phase 2

DOC Group B (DOC Group B)

Non-hodgkin Lymphoma; Hodgkin Lymphoma · Non-hodgkin Lymphoma

#Non-hodgkinLymphoma#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 30상태 RECRUITING
ADCBiologicstaleCullinan Therapeutics Inc.Phase 1

Dato-DXd (Datopotamab deruxtecan-dlnk, Datopotamab deruxtecan-dlnk (Dato-DXd))

Advanced Solid Tumor; NSCLC · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
효능 ORR 74%임상시험 30상태 RECRUITING
ADCBiologicstaleVerastem, Inc.Phase 2

Defactinib (Defactinib)

Advanced Lymphoma; Advanced Malignant Solid Neoplasm · FRα

#FR#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
효능 ORR 3.2%임상시험 30상태 RECRUITING
ADCBiologicstaleAstraZenecaApproved

Dexamethasone mouthwash (Dexamethasone mouthwash)

Stomatitis · Stomatitis

#Stomatitis#ADC#Approved#항체약물접합체#antibody-drug-conjugate+1
임상시험 30상태 RECRUITING
AntibodystaleRochePhase 3

trastuzumab (Herceptin, Docetaxel combined + Trastuzumab +Pertuzumab)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Phase3#항체#면역항체+2
효능 ORR 91.8%임상시험 30상태 RECRUITING
AntibodystaleRochePreclinical

trastuzumab (Herceptin, Docetaxel combined with Trastuzumab±Pertuzumab)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Preclinical#항체#면역항체+2
효능 ORR 91.8%임상시험 30상태 ACTIVE
ADCBiologicstaleHoffmann-La RochePhase 2

Docetaxel or Nab-paclitaxel (Docetaxel or Nab-paclitaxel)

Breast Cancer · Breast Cancer

#BreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
효능 ORR 23.1%임상시험 30상태 RECRUITING
ADCBiologicstaleAmgenPreclinical

Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine (Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine)

Anti-CD30; Brentuximab · CD30

#CD30#ADC#Preclinical#항체약물접합체#antibody-drug-conjugate+3
효능 ORR 86%임상시험 30상태 ACTIVE

33 / 209 페이지

← 이전다음 →